Trikafta, a triple combination therapy for CF in patients with specific gene mutations, reaches endpoint in Phase III clinical trial The crisis of purchasing imported consumables in bulk in 10 provinc ...
Johnson & Johnson terminates global Phase III clinical trial of Stelara for the treatment of systemic lupus erythematosus Trikafta, a triple combination therapy for CF in patients with specific gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback